SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-20-049964
Filing Date
2020-04-23
Accepted
2020-04-23 07:00:42
Documents
5
Period of Report
2020-06-05
Effectiveness Date
2020-04-23

Document Format Files

Seq Description Document Type Size
1 DEF 14A tm2015427-1_def14a.htm DEF 14A 1265049
2 GRAPHIC lg_anipharma-black.jpg GRAPHIC 102746
3 GRAPHIC sg_stephen-carey.jpg GRAPHIC 79707
4 GRAPHIC tm2015427d1-pc1_votebw.jpg GRAPHIC 3525038
5 GRAPHIC tm2015427d1-pc2_votebw.jpg GRAPHIC 2632706
  Complete submission text file 0001104659-20-049964.txt   8823403
Mailing Address 210 MAIN STREET WEST BAUDETTE MN 56623
Business Address 210 MAIN STREET WEST BAUDETTE MN 56623 2186343500
ANI PHARMACEUTICALS INC (Filer) CIK: 0001023024 (see all company filings)

IRS No.: 582301143 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-31812 | Film No.: 20809159
SIC: 2834 Pharmaceutical Preparations